chikungunya

Documents about chikungunya

• Trial of an Inactivated Chikungunya Virus Vaccine#123551ClinicalTrials.gov
• A Phase I Study of PepGNP-ChikV in Healthy Volunteers#387221ClinicalTrials.gov
• Post-chikungunya chronic arthralgia in Burkina Faso: Frequency and associated factors#127897PLOS
• Chikungunya Virus Detection in Semen#865075ClinicalTrials.gov
• Chikungunya Arthritis in the Americas#813782ClinicalTrials.gov
• Chikungunya Virus Vaccine Trial in Healthy Adults#180224ClinicalTrials.gov
• Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine#897913ClinicalTrials.gov
• Chikungunya virus at a crossroads: Emergence, interventions, and global health strategies.#13867PubMed
• Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine#249660ClinicalTrials.gov
• Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)#127660ClinicalTrials.gov
• Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults#261348ClinicalTrials.gov
• Chikungunya outbreak in eastern Senegal, 2023#300955HAL (France)
• RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection#862921ClinicalTrials.gov
• Producción científica mundial sobre el virus Chikungunya: Análisis bibliométrico de su evolución y tendencias temáticas 2015–2025#265764Repositorio Institucional de la Universidad Señor de Sipán
• Impact of the Chikungunya Outbreak in Reunion Island on the Quality of Life After 10 Years#806614ClinicalTrials.gov
• Chikungunya virus in dengue-suspected patients: Molecular evidence from the 2019 outbreak in Yangon, Myanmar#152675PLOS
• Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)#435767ClinicalTrials.gov
• Avaliação da atividade antiviral de Byrsonima aerugo contra o vírus Chikungunya.#446807REPOSITORIO INSTITUCIONAL DA UFOP
• Characterization and control of emerging viral diseases in Cambodia : insights from bat coronaviruses and chikungunya virus#333872HAL (France)
• Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults#829624ClinicalTrials.gov
• Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia#158040ClinicalTrials.gov
• Overview of chikungunya viral transmission, French Guiana, 2026#268489HAL (France)
• Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)#914484ClinicalTrials.gov
• Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults#898874ClinicalTrials.gov
• Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Participants#859818ClinicalTrials.gov
• Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection#904862ClinicalTrials.gov
• Modeling and control of Chikungunya with chronic infection#5631Europe PMC
• Research advances in chikungunya virus: Epidemiology, pathogenesis, and control#123294Europe PMC
• Somali Version of the Chikungunya KAP Questionnaire Used in Burao, Somaliland (2025)#127111DataCite
• Dinâmica da transmissão de chikungunya e associação com indicadores de vulnerabilidade social no Brasil#289190Repositório Institucional da Universidade Federal de Sergipe
• Dengue and chikungunya interface in South and Southeast Asia: Epidemiology, challenges and future directions.#193909PubMed
• Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa#268048ClinicalTrials.gov
• Somali and English Versions of the Chikungunya KAP Questionnaire Used in Burao, Somaliland (2025)#127110DataCite
• Somali and English Versions of the Chikungunya KAP Questionnaire Used in Burao, Somaliland (2025)#127112DataCite
• Chikungunya virus nsP2: Insights into viral replication, pathogenesis, and therapeutic targeting#231375Europe PMC
• Potencial terapêutico da silimarina na artrite e miosite induzidas pelos vírus Chikungunya e Mayaro.#434686REPOSITORIO INSTITUCIONAL DA UFOP
• Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults#640454ClinicalTrials.gov
• Avaliação da potencial atividade antiviral de uma nanoemulsão de óleo de Copaifera sp. (Copaíba) contra o vírus chikungunya#320859RI UFPE
• Synthesis, screening and validation of cysteine-reactive fragments as chikungunya virus protease inhibitors#368421Open Research
• Effects of Auriculotherapy on Pain and Functional Capacity of Individuals With Chikungunya Fever#862926ClinicalTrials.gov
• The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return Travelers#851175ClinicalTrials.gov
• Oral Ivermectin for Chikungunya Viral Infection#121440ClinicalTrials.gov
• Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Réunion#136407ClinicalTrials.gov
• Direct RNA Sequencing of Dengue and Chikungunya Viruses with Ultra-Low Input and Custom Multiplexing#326280HAL (France)
• Impact of climate change on the global circulation of chikungunya virus: current evidence, future projections, and adaptation strategies#642521Europe PMC
• Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.#300326ClinicalTrials.gov
• A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.#454074ClinicalTrials.gov
• Utility of sentinel surveillance as an early warning system for emerging pathogens in a low-resource setting: Correlations of dengue, chikungunya, Zika, and COVID-19 trends between sentinel and passive surveillance systems in Puerto Rico, 2012–2023#275938PLOS
• Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)#914254ClinicalTrials.gov
• Impaired Brain Growth in Children Perinatally Infected With Chikungunya#322523HAL (France)